Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxygen-15 water is a radiopharmaceutical tracer used in positron emission tomography (PET) imaging to measure and quantify regional blood flow (perfusion). In the context of clinical research conducted by the National Cancer Institute (NCI), it is utilized as a diagnostic tool to evaluate the vascular characteristics and biological activity of tumors, such as renal cell carcinomas in patients with von Hippel-Lindau (VHL) disease. The tracer is administered intravenously and distributes throughout the body's water space in proportion to blood flow, allowing for the non-invasive assessment of tumor hemodynamics and the evaluation of pharmacodynamic responses to experimental therapies like 17AAG.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxygen-15 water.